 |
|
|
| |
Safety and Efficacy of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Hepatitis C in Patients Aged 65 Years or Older:
A Retrospective Analysis of International Phase 3 Studies
|
| |
| |
Reported by Jules Levin
DDW 2015 - Digestive Disease Week 2015, May 16-19, 2015, Washington D.C.
S Saab,1 M Mizokami,2 M Omata,3 A Mangia,4 E Eggleton,5 S Seyedkazemi,5 Y Zhu,5 SJ Knox,5 P Pang,5 M Subramanian,5 K Kowdley,6 NH Afdhal7
1University of California Los Angeles, Los Angeles, CA, United States; 2National Center for Global Health and Medicine, Tokyo, Japan; 3Yamanashi Prefectural Hospital Organization, Yamanashi, Japan; 4Liver Unit, Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy; 5Gilead Sciences, Foster City, CA, United States; 6Swedish Medical Center, Seattle, WA, United States; 7Beth Israel Deaconess Medical Center, Boston, MA, United States
|
| |
|
|
|
|
|
